Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669–85. https://doi.org/10.1001/jama.2021.0106.

Article  PubMed  CAS  Google Scholar 

Keller DSBM, Perez RO, et al. The multidisciplinary management of rectal cancer. Nat Rev Gastroenterol Hepatol. 2020;17(7):414–29. https://doi.org/10.1038/s41575-020-0275-y.

Article  PubMed  Google Scholar 

You YN, Hardiman KM, Bafford A, et al. The American Society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer. Dis Colon Rectum. 2020;63(9):1191–222. https://doi.org/10.1097/DCR.0000000000001762.

Article  PubMed  Google Scholar 

Cremolini C, Antoniotti C, Lonardi S, et al. Activity and safety of cetuximab plus modified FOLFOXIRI followed by maintenance with cetuximab or bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a randomized phase 2 clinical trial. JAMA Oncol. 2018;4(4):529–36. https://doi.org/10.1001/jamaoncol.2017.5314.

Article  PubMed  PubMed Central  Google Scholar 

Bennouna J, Hiret S, Bertaut A, et al. Continuation of bevacizumab vs cetuximab plus chemotherapy after first progression in KRAS wild-type metastatic colorectal cancer: the UNICANCER PRODIGE18 randomized clinical trial. JAMA Oncol. 2019;5(1):83–90. https://doi.org/10.1001/jamaoncol.2018.4465.

Article  PubMed  Google Scholar 

Zhu G, Pei L, Xia H, et al. Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Mol Cancer. 2021;20(1):143. https://doi.org/10.1186/s12943-021-01441-4.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Von Moos R, Koeberle D, Schacher S, et al. Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: a phase I/II trial (SAKK 41/08). Eur J Cancer. 2018;89:82–9. https://doi.org/10.1016/j.ejca.2017.11.005.

Article  CAS  Google Scholar 

Radanova M, Mihaylova G, Stoyanov GS, et al. KRAS mutation status in bulgarian patients with advanced and metastatic colorectal cancer. Int J Mol Sci. 2023; 24(16)

Dienstmann R, Connor K, Byrne AT, et al. Precision therapy in RAS mutant colorectal cancer. Gastroenterology. 2020;158(4):806–11. https://doi.org/10.3390/ijms241612753.

Article  PubMed  CAS  Google Scholar 

Pfeiffer P, Qvortrup C. KRAS(G12C) inhibition in colorectal cancer. Lancet Oncol. 2022;23(1):10–1. https://doi.org/10.1016/S1470-2045(21)00652-5.

Article  PubMed  CAS  Google Scholar 

Asawa P, Bakalov V, Kancharla P, et al. The prognostic value of KRAS mutation in locally advanced rectal cancer. Int J Colorectal Dis. 2022;37(5):1199–207. https://doi.org/10.1007/s00384-022-04167-x.

Article  PubMed  Google Scholar 

Zhang Y, Wu Z, Zhang B, et al. Prognostic impact of high-risk factors and KRAS mutation in patients with stage II deficient mismatch repair colon cancer: a retrospective cohort study. Ann Transl Med. 2022;10(12):702. https://doi.org/10.21037/atm-22-2803.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kitsel Y, Cooke T, Sotirchos V, et al. Colorectal cancer liver metastases: genomics and biomarkers with focus on local therapies. Cancers. 2023;15(6):1679. https://doi.org/10.3390/cancers15061679.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yang L, Dong D, Fang M, et al. Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer? Eur Radiol. 2018;28(5):2058–67. https://doi.org/10.1007/s00330-017-5146-8.

Article  PubMed  Google Scholar 

Sclafani F, Chau I, Cunningham D, et al. KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer. Sci Rep. 2018;8(1):1445. https://doi.org/10.1038/s41598-018-19212-5.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Qi Y, Zhao T, Han M. The application of radiomics in predicting gene mutations in cancer. Eur Radiol. 2022;32(6):4014–24. https://doi.org/10.1007/s00330-021-08520-6.

Article  PubMed  CAS  Google Scholar 

Chen S, Jiang L, Gao F, et al. Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma. Br J Cancer. 2022;126(5):771–7. https://doi.org/10.1038/s41416-021-01640-2.

Article  PubMed  CAS  Google Scholar 

Sato M, Morimoto K, Kajihara S, et al. Machine-learning approach for the development of a novel predictive model for the diagnosis of hepatocellular carcinoma. Sci Rep. 2019;9(1):7704. https://doi.org/10.1038/s41598-019-44022-8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shew M, New J, Bur AM. Machine learning to predict delays in adjuvant radiation following surgery for head and neck cancer. Otolaryngol Head Neck Surg. 2019;160(6):1058–64. https://doi.org/10.1177/0194599818823200.

Article  PubMed  Google Scholar 

Ingwersen EW, Stam WT, Meijs BJV, et al. Machine learning versus logistic regression for the prediction of complications after pancreatoduodenectomy. Surgery. 2023;174(3):435–40. https://doi.org/10.1016/j.surg.2023.03.012.

Article  PubMed  Google Scholar 

Patel H, Shah H, Patel G, et al. Hematologic cancer diagnosis and classification using machine and deep learning: State-of-the-art techniques and emerging research directives. Artif Intell Med. 2024;152:102883. https://doi.org/10.1016/j.artmed.2024.102883.

Article  PubMed  Google Scholar 

Wu X, Li Y, Chen X, et al. Deep learning features improve the performance of a radiomics signature for predicting KRAS status in patients with colorectal cancer. Acad Radiol. 2020;27(11):e254–62. https://doi.org/10.1016/j.acra.2019.12.007.

Article  PubMed  Google Scholar 

Zhang Z, Shen L, Wang Y, et al. MRI radiomics signature as a potential biomarker for predicting KRAS status in locally advanced rectal cancer patients. Front Oncol. 2021;11:614052. https://doi.org/10.3389/fonc.2021.614052.

Article  PubMed  PubMed Central  CAS  Google Scholar 

He P, Zou Y, Qiu J, et al. Pretreatment (18)F-FDG PET/CT imaging predicts the KRAS/NRAS/BRAF gene mutational status in colorectal cancer. J Oncol. 2021;2021:6687291. https://doi.org/10.1155/2021/6687291.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ganzer R, Mangold A, Siokou FS, et al. Value of magnetic resonance imaging/ultrasound fusion prostate biopsy to select patients for focal therapy. World J Urol. 2022;40(11):2689–94. https://doi.org/10.1007/s00345-022-04157-2.

Article  PubMed  CAS  Google Scholar 

Dong X-Y, Li Q-M, Xue W-L, et al. Diagnostic performance of endorectal ultrasound combined with shear wave elastography for rectal tumors staging. Clin Hemorheol Microcircul. 2023;84(4):399–411. https://doi.org/10.3233/CH-231716.

Article  CAS  Google Scholar 

Mao N, Shi Y, Lian C, et al. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography. Eur Radiol. 2022;32(5):3207–19. https://doi.org/10.1007/s00330-021-08414-7.

Article  PubMed  CAS  Google Scholar 

Huang Z, Mo S, Wu H, et al. Optimizing breast cancer diagnosis with photoacoustic imaging: an analysis of intratumoral and peritumoral radiomics. Photoacoustics. 2024;38:100606. https://doi.org/10.1016/j.pacs.2024.100606.

Article  PubMed  PubMed Central  Google Scholar 

Wang SR, Cao CL, Du TT, et al. Machine learning model for predicting axillary lymph node metastasis in clinically node positive breast cancer based on peritumoral ultrasound radiomics and SHAP feature analysis. J Ultrasound Med. 2024. https://doi.org/10.1002/jum.16483.

Article  PubMed  PubMed Central